Bladder Neoplasm — Trials

Bladder Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06443944	An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG	available	—	—	CG Oncology, Inc.INDUSTRY	1	Sep 11, 2026	clinicaltrials
NCT07675057	Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors	available	—	—	Eli Lilly and CompanyINDUSTRY	0	Jun 30, 2026